Number of Shares
1.15 Mil
Current Holdings Value*
$122.83 Mil
% of Portfolio
9.04%
Total Estimate Gain
$-11.16 Mil
% of Total Estimate Gain
-3.13%

Fidelity Advisor Biotechnology Fund's Gilead Sciences Inc Holding Summary

As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 1.15 Mil shares of Gilead Sciences Inc(GILD), totaling $122.83 Mil. This investment constitutes 9.04% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.09% of the outstanding Gilead Sciences Inc(GILD) stock.

The initial trade took place in 2019Q4. And since then Fidelity Advisor Biotechnology Fund has made 5 purchases of GILD, at an average price of $84.93, for a total of 4.20 Mil shares. In addition, there have been 6 sales at an average price of $72.45 for 3.05 Mil shares. Based on historical transaction data and GILD's current price of $108.22, Fidelity Advisor Biotechnology Fund's estimated gain on his GILD holdings is $-11.16 Mil, reflecting a -3.13% gain to date.

Fidelity Advisor Biotechnology Fund GILD ($108.22) Holding Chart

Fidelity Advisor Biotechnology Fund GILD ($108.22) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1